<< Back
![April 1- 4, 2024, Drug Discovery Chemistry](https://aurigene-com.b-cdn.net/wp-content/uploads/2022/11/2-1.jpg)
April 1- 4, 2024, Drug Discovery Chemistry
1) A Highly Differentiated Small Molecule Immune Checkpoint Inhibitor Dually Targeting PD-L1 And A2AR for Cancer Therapy
2) Targeting CBM, A Tri Protein Signalling Hub, by Inhibition Of MALT1 for the Treatment Of B- Cell Lymphomas